GlassScriptPhysician profile
Raphael N Ngengwe
NPI 1699865857
$47,499.95
in general payments reported to CMS, 2019-2025
19 companies · $10K in 2025
The $10K reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,885 · 2020: $1,396 · 2021: $8,924 · 2022: $9,927 · 2023: $2,729 · 2024: $7,538 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $5,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,774.92 |
| Travel and Lodging | $5,593.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,805.13 | 2019-2025 | Aveir, Ensite, Gallant |
| Biosense Webster, INC. | $11,765.84 | 2019-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $9,591.45 | 2021-2022 | |
| Medtronic, INC. | $4,789.68 | 2024-2025 | Linq II, Micra, Affera Mapping System |
| Medtronic Vascular, INC. | $1,873.36 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $1,347.92 | 2023 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $493.07 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $249.41 | 2020-2025 | Bodyguardian |
| Angiodynamics, INC. | $203.44 | 2019 | |
| Pfizer INC. | $112.27 | 2019-2025 | |
| Biotronik INC. | $111.48 | 2025 | Acticor 7 Vr-T Dx |
| Novartis Pharmaceuticals Corporation | $51.79 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $19.21 | 2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $16.86 | 2020 | |
| Amgen INC. | $16.19 | 2025 | Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $15.12 | 2019 | |
| Recor Medical INC | $13.71 | 2025 | Paradise Ultrasound Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.95 | 2019 | |
| Cardinal Health 200 LLC | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Ngengwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.